Is Remedium Lifecare a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Remedium Lifecare Ltd is a average quality company .

Is Remedium Lifecare undervalued or overvalued?

The key valuation ratios of Remedium Lifecare Ltd's currently when compared to its past seem to suggest it is in the Fair zone .

What is Remedium Lifecare share price return in the past 10 years?

Data is not available for this company

Is Remedium Lifecare a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Remedium Lifecare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

Remedium Lifecare Ltd - Stock Valuation and Financial Performance

Name: Remedium Lifecare
Brand: Remedium Lifecare

BSE: 539561 | NSE: | Trading | Small Cap

Place order

Remedium Lifecare Share Price

₹6.07 -0.12 -1.94%
as on 21-Nov'24 16:59

10 Year X-Ray of Remedium Lifecare:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	24.6%	0.7%	0.1%	0.6%	0.6%	11.2%	7.4%	18.2%	102.5%	99.5%	-
Value Creation Index ⓘ	0.8	-1.0	-1.0	-1.0	-1.0	-0.2	-0.5	0.3	6.3	6.1	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	2.1	3.9	1.3	0.4	0.2	2.9	90	505	510	4,042	3,345
Sales YoY Gr.	-	85.4%	-66.2%	-73.7%	-54.3%	1,706.3%	3,015.2%	460.7%	1%	692.7%	-
Adj EPS ⓘ	0	0	0	0	0	0	0	0	0.1	0.5	0.5
YoY Gr.	-	-100%	NA	NA	NA	NA	0%	200%	300%	275%	-
BVPS (₹) ⓘ	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	1.1	1.1
Adj Net Profit ⓘ	0.6	0	0	0	0	0.3	0.5	1.1	4.9	18	19
Cash Flow from Ops. ⓘ	0.1	-1.4	0.1	-0.2	-0.1	-0.2	-10.2	11.3	20.5	-74.2	-
Debt/CF from Ops. ⓘ	1.2	0	0	0	-1.1	-1.8	-1	0	0	-0.8	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	131.5%	659.4%	255.4%	692.7%
Adj EPS ⓘ	52.7%	NA	255.7%	275%
BVPSⓘ	33.4%	68%	120.4%	311.5%
Share Price	-	97.9%	72.1%	-77.2%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	21.4	0.3	0.1	0.5	0.2	8.4	13.3	24.5	63.4	67.7	41.6
Op. Profit Mgn % ⓘ	-7.8	-7.6	-7.4	0.2	-43.2	13.4	0.8	0.4	1.4	0.9	0.7
Net Profit Mgn % ⓘ	27.7	0.2	0.3	3.9	3.9	9.4	0.5	0.2	1	0.5	0.6
Debt to Equity ⓘ	0	0	0	0	0	0.1	2.7	0	0	1.3	0
Working Cap Days ⓘ	867	415	1,050	3,243	6,366	351	82	94	485	139	1,961
Cash Conv. Cycle ⓘ	663	325	801	2,189	2,045	110	10	17	27	21	43

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 255.41%

Net Profit is growing at healthy rate in last 3 years 255.69%

Sales growth is good in last 4 quarters at 632.94%

Return on Equity has declined versus last 3 years average to 41.60%

Latest Financials - Remedium Lifecare Ltd.

	Standalone	Consolidated
TTM EPS (₹)	0.5	-
TTM Sales (₹ Cr.)	3,345	-
BVPS (₹.) ⓘ	1.1	-
Reserves (₹ Cr.) ⓘ	6	-
P/BV ⓘ	5.44	-
PE ⓘ	13.52	-

From the Market
52 Week Low / High (₹)	5.29 / 38.25
All Time Low / High (₹)	0.10 / 44.91
Market Cap (₹ Cr.)	250
Equity (₹ Cr.)	40.3
Face Value (₹)	1
Industry PE ⓘ	69

Management X-Ray of Remedium Lifecare:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Remedium Lifecare

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Remedium Lifecare

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	2	4	1	0	0	3	90	505	510	4,042
Operating Expenses ⓘ	2	4	1	0	0	3	89	503	503	4,008
Manufacturing Costs	0	1	1	0	0	0	0	2	2	1
Material Costs	2	3	0	0	0	2	88	498	494	4,001
Employee Cost	0	0	0	0	0	0	0	0	1	0
Other Costs ⓘ	0	0	0	0	0	1	1	3	7	5
Operating Profit ⓘ	0	0	0	0	0	0	1	2	7	34
Operating Profit Margin (%)	-7.9%	-7.6%	-7.4%	0.2%	-43.2%	13.4%	0.8%	0.4%	1.4%	0.8%
Other Income ⓘ	1	0	0	0	0	0	0	0	1	21
Interest ⓘ	0	0	0	0	0	0	0	0	0	5
Depreciation ⓘ	0	0	0	0	0	0	0	0	0	0
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	1	0	0	0	0	0	1	2	7	50
Tax ⓘ	0	0	0	0	0	0	0	0	2	18
Profit After Tax	1	0	0	0	0	0	0	1	5	33
PAT Margin (%)	27.7%	0.3%	0.3%	3.9%	5.0%	9.6%	0.5%	0.2%	1.1%	0.8%
Adjusted EPS (₹)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	3	3	3	3	3	3	4	5	10	43
Share Capital ⓘ	4	4	4	4	4	4	4	4	4	10
Reserves ⓘ	-1	-1	-1	-1	-1	0	0	1	7	33
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	0	0	0	0	0	0	11	0	0	58
Long Term Debt	0	0	0	0	0	0	11	0	0	0
Short Term Debt	0	0	0	0	0	0	0	0	0	58
Trade Payables	2	1	0	0	0	0	24	125	84	712
Others Liabilities ⓘ	0	0	0	0	0	0	0	94	1,060	1,135
Total Liabilities ⓘ	6	5	3	3	4	4	39	224	1,154	1,948
Fixed Assets
Gross Block	2	0	0	0	0	0	0	0	0	0
Accumulated Depreciation	1	0	0	0	0	0	0	0	0	0
Net Fixed Assetsⓘ	1	0	0	0	0	0	0	0	0	0
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investmentsⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	1	1	0	0	0	1	3	84	7	133
Trade Receivables	2	3	2	2	0	1	24	64	172	921
Cash Equivalents	0	0	0	0	1	1	1	1	22	2
Others Assetsⓘ	1	1	1	1	2	1	11	74	953	892
Total Assets ⓘ	6	5	3	3	4	4	39	224	1,154	1,948

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	0	-1	0	0	0	-10	11	21	-74
PBT ⓘ	1	0	0	0	0	1	2	7	50
Adjustment ⓘ	0	0	0	0	0	0	0	0	4
Changes in Working Capital ⓘ	-1	-1	-0	0	-1	-11	10	15	-111
Tax Paid ⓘ	0	0	0	0	0	0	0	-2	-18
Cash Flow From Investing Activity ⓘ	0	1	0	1	0	0	0	0	0
Capex	0	1	0	0	0	0	0	0	0
Net Investments	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	1	0	0	0	0	0
Cash Flow From Financing Activityⓘ	0	0	0	0	0	10	-11	0	54
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	10	-11	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0	-4
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	0	0	58
Net Cash Flow ⓘ	0	0	0	1	0	0	1	20	-20

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	21.4	0.36	0.11	0.45	0.26	8.62	13.33	24.51	70.92	122.76
ROCE (%)	24.6	0.66	0.14	0.55	0.62	11.16	7.39	18.16	102.54	99.51
Asset Turnover Ratio	0.32	0.76	0.34	0.11	0.05	0.74	4.21	3.85	0.74	2.61
PAT to CFO Conversion(x)	0	N/A	N/A	N/A	N/A	N/A	N/A	11	4.2	-2.24
Working Capital Days
Receivable Days	383	224	688	2,189	2,487	103	51	32	85	49
Inventory Days	280	100	0	0	470	57	8	31	33	6
Payable Days	0	0	0	0	1,426	81	50	54	77	36

Remedium Lifecare Ltd Stock News

Remedium Lifecare Ltd FAQs

What is the share price of Remedium Lifecare?

Company share prices are keep on changing according to the market conditions. The closing price of Remedium Lifecare on 21-Nov-2024 16:59 is ₹6.07.

What is the market cap of Remedium Lifecare?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Nov-2024 16:59 the market cap of Remedium Lifecare stood at ₹249.6.

What is the P/E ratio of Remedium Lifecare?

The latest P/E ratio of Remedium Lifecare as of 21-Nov-2024 16:59 is 13.52.

What is the P/B ratio of Remedium Lifecare?

The latest P/B ratio of Remedium Lifecare as of 21-Nov-2024 16:59 is 5.44.

What is the 52-week high and low of Remedium Lifecare?

The 52-week high of Remedium Lifecare is ₹38.25 and the 52-week low is ₹5.29.

What is the TTM revenue of Remedium Lifecare?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Remedium Lifecare is ₹3,345 ( Cr.) .

About Remedium Lifecare Ltd

Remedium Lifecare Ltd. (formerly known as Roxy Exports Limited) is a BSE listed company. The company has made a paradigm shift by entering into the manufacturing of intermediates and APIs and be reckoned as a leading contract manufacturer and as a brand owner of advanced intermediates & APIs. The strategic acquisition of the state-of-the-art manufacturing facilities in Hyderabad, was a timely move to forward integrate and diversify into the pharma & healthcare arena. A massive facility with 2 dedicated manufacturing blocks is now ready for large scale manufacture.

The company is engaged into the business of trading in API Intermediates (KSMs & CRMs) and various other raw materials used in API trading viz. Amino isophthalic Acid, Tellurium (IV) Oxide, Grignard Reagent, lodine, Selenium Metal Powder, Trimethyl Sulfoxonium lodide (TMSI).

Business area of the company

The company is pharmaceutical company aligned across two business verticals viz. Products and Services. Its Products business comprises manufacture and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both Domestic and International markets including the regulated markets.